RTOG-0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort.
Carole A FakhrySakshi R TewariLisa ZhangMelina J WindonElaine O BigelowVirginia E DrakeLisa M RooperTanya TroyPatrick HaBrett A MilesWojciech K MydlarzDavid W EiseleGypsyamber D'SouzaPublished in: Cancer (2021)
In patients with OPC, the RTOG-0129 RPA model is associated with OS and PFS in a heterogeneously treated cohort.